Our Collaboration With Medicilon
One-stop world-class preclinical R&D services
Hoeford Research has joined forces with global preclinical CRO Medicilon offering access to expertise and laboratories in China and U.S. to meet demand from drug developers and investors for innovative, world-class preclinical research and testing services.
Expertise and Resources
The collaboration between Hoeford and Medicilon brings together the expertise of a UK team that is dedicated to regulatory toxicology research, and the robust resources and vast network of a global preclinical research organisation.
The result is world-class research and testing services set to accelerate your programme while ensuring that critical data necessary to support go/no go decisions and inform regulatory determinations is available, accurate and correctly interpreted at every step.
Quality and Confidence
This partnership means enhanced services for UK and Europe-based customers. It also means faster, more efficient preclinical testing. And it means high quality results that satisfy regulators. Ultimately it means getting your product to market with confidence.
Hoeford leverages its 60-year heritage of excellence in regulatory testing to provide you with managed access to Medicilon's 84,600 square metres of laboratory space, 3,100 scientists and service personnel, and a track record of almost 400 projects successfully registered with regulatory authorities over 20 years.
The Hoeford Medicilon collaboration combines Hoeford's commitment to excellence with Medicilon's scale and reach.
It offers pharmaceutical companies a streamlined, cost effective and high quality path through the preclinical stages of drug development.
And most importantly, it brings us one step closer to the next breakthrough in medicine.
Click here to learn more about integrated preclinical candidate development and pre-IND safety and efficacy solutions.
What customers have to say...
